Taurine improves congestive functions in a mouse model of fragile X syndrome

Advances in Experimental Medicine and Biology

Volumn 643, Issue , 2009, Pages 191-198

  El Idrissi, Abdeslem ^a   Boukarrou, Latifa ^b   Dokin, Carl ^b   Brown, W Ted ^b  

^a CITY UNIVERSITY OF NEW YORK   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; GLUTAMATE DECARBOXYLASE; TAURINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; AVOIDANCE BEHAVIOR; BIOCHEMISTRY; CONFERENCE PAPER; CONTROLLED STUDY; DIET SUPPLEMENTATION; DISEASE PREDISPOSITION; FRAGILE X SYNDROME; GABAERGIC SYSTEM; LEARNING DISORDER; MEMORY; MEMORY CONSOLIDATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; SEIZURE; TASK PERFORMANCE; ANIMAL; ARTICLE; DISEASE MODEL; DRUG EFFECT; PATHOPHYSIOLOGY;

MUS;

ANIMALS; AVOIDANCE LEARNING; DISEASE MODELS, ANIMAL; FRAGILE X SYNDROME; MICE; TAURINE;

EID: 63149126099     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-0-387-75681-3_19     Document Type: Conference Paper

References (20)

1. Bakker CE, Verheij C, Willemsen R, van der Helm R, Oerlemans F, Vermeij M, Bygrave A, Hoogeveen AT, Oostra BA, Reyniers E, De Boulle K, DHooge R, Cras P, van Velzen D, Nagels G, Marti JJ, De Deyn P, Darby JK, Willems PJ (1994) Fmr1 knockout mice: a model to study fragile X mental retardation. Cell 78:23-33
2. Chen L, Toth M (2001) Fragile X mice develop sensory hyperreactivity to auditory stimuli Neurosci 103:1043-1050
3. del Olmo N, Bustamante, J, del Rio RM, Soli J (2000) Taurine activates GABA(A) but not GABA(B) receptors in rat hippocampal CA1 area. Brain Res 864 298-307
4. El Idrissi A, Ding X-H, Scalia J, Trenkner E, Brown WT, Dobkin C (2005) Decreased GABAA receptor expression in the seizure-prone fragile X mouse. Neurosci Lett 377:141-146
5. El Idrissi A, Trenkner E (2003) Taurine regulates mitochondrial calcium homeostasis. In: Lombardini JB, Schaffer SW, Azuma J (eds) Taurine 5 Beginning the 21st Century, Adv Exp Med Biol, Vol 526, Kluwer Press, NewYork, pp 527-536
6. El Idrissi A, Trenkner E (2004) Taurine as a modulator of excitatory and inhibitory neurotransmission. Neurochem Res 29:189-197
7. El Idrissi A, Messing J, Scalia J, Trenkner E (2003) Prevention of Epileptic Seizures through taurine. Adv Exp Med Biol 526: 515-525
8. El Idrissi A, Trenkner E (1999) Growth factors and taurine protect against excitotoxicity by stabilizing calcium homeostasis and energy metabolism. J Neurosci 19:9459-9468
9. Hagerman RJ (2002) Physical and behavioral phenotype. In: Hagerman RJ, Hagerman PJ (eds) Fragile X syndrome Diagnosis, treatment and research, Johns Hopkins University Press, Baltimore, pp 3-109
10. Huxtable RJ (1989) Taurine in the central nervous system and the mammalian action actions of taurine. Prog Neurobiol 32:471-533
11. Levinskaya N, Trenkner E, El Idrissi A (2006) A Increased GAD-positive neurons in the cortex of taurine-fed mice. Adv Exp Med Biol 583 411-417
12. Kuriyama K, Hashimoto T (1998) Interrelationship between taurine and GABA. Adv Exp Med Biol 442:329-337
13. Mellor JR, Gunthorpe MJ, Randall AD (2000) The taurine uptake inhibitor guanidinoethyl sulphonate is an agonist at gamma-aminobutyric acid(A) receptors in cultured murine cerebellar granule cells. Neurosci Lett 286:25-28
14. Musumeci SA, Bosco P, Calabrese G, Bakker C, De Sarro GB, Elia M, Ferri R, Oostra BA (2000) Audiogenic seizures susceptibility in transgenic mice with fragile X syndrome. Epilepsia 41:19-23
15. Quinn MR, Harris CL (1995) Tautine allosterically inhibits binding of [35S]-tbutylbicyclophosphorothionate (TBPS) to rat brain synaptic membranes. Neuropharmacol 34:1607-1613
16. Riback CE, Lauterborn JC, NavettaMS, Gall CM (1993) The inferior colliculus of GEPRs contains greater numbers of cells that express glutamate decarboxylase (GAD67) mRNA. Epilepsy Res 14:105-113
17. Sturman JA (1993) Taurine in development. Physiol Rev 73:119-147
18. Wisniewski KE, Segan SM, Miezejeski CM, Sersen EA, Rudelli RD (1991) The Fra(X) syndrome: neurological, electrophysiological, and neuropathological abnormalities. Am J Med Genet 38:476-480
19. Wu JY, Tang XW, Schloss JV, Faiman MD (1998) Regulation of taurine biosynthesis and its physiological significance in the brain. Adv Exp Med Biol 442:339-345
20. Yan QJ, Asafo-adjei PK, Arnold HM, Brown RE, Bauchwitz RP (2004) A phenotypic and molecular characterization of the fmr1-tm 1 Cgr fragile X mouse. Genes Brain Behav 3:337-359